Publications | CDI Pathogenesis and Therapy - Wang Lab at Biomedical Sciences of HCOM

2018

Wang, Shaohua. 2018. “Genome Engineering of Clostridium Difficile Using the CRISPR-Cas9 System.”

Wang, Shaohua. 2018. “Obesity-Linked Gut Microbiome Dysbiosis Associated With Derangements in Gut Permeability and Intestinal Cellular Homeostasis Independent of Diet.”

Wang, Shaohua. 2018. “Comparative Microbiome Signatures and Short-Chain Fatty Acids in Mouse, Rat, Non-Human Primate, and Human Feces.”

Wang, Shaohua. 2018. “Human-Origin Probiotic Cocktail Increases Short-Chain Fatty Acid Production via Modulation of Mice and Human Gut Microbiome.”

Wang, Shaohua. 2018. “Gut Microbiome and Aging: Physiological and Mechanistic Insights.”

2017

Wang, Shaohua. 2017. “Enhancement of Solvent Production by Overexpressing Key Genes of the Acetone-Butanol-Ethanol Fermentation Pathway in Clostridium Saccharoperbutylacetonicum N1-4.”

Wang, Shaohua. 2017. “Dietary Polysaccharides in the Amelioration of Gut Microbiome Dysbiosis and Metabolic Diseases.”

Wang, Shaohua. 2017. “Genome Editing in Clostridium Saccharoperbutylacetonicum N1-4 With the CRISPR-Cas9 System.”

2016

Wang, Shaohua. 2016. Genetically engineered bacterium for producing natamycin as well as construction method and application of genetically engineered bacterium, issued 2016.

Wang, Shaohua. 2016. “Improvement of Natamycin Production by Cholesterol Oxidase Overexpression in Streptomyces Gilvosporeus.”